HTFLNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Heartflow, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$51.02+2.73 (+5.65%)
Close on Oct 19, 2026
- Market cap
- $4.41B
- P/E (TTM)
- –
- Dividend yield
- –
Heartflow, Inc. revenue by segment
By business segment
By product or service
By region
| Revenue | FY2025 | FY2024 | FY2023 | % of revenue | YoY |
|---|---|---|---|---|---|
| United States | $162.73M | $115.04M | $77.73M | 92.4% | +41.5% |
| Rest of World [Member] | $13.30M | $10.77M | $9.45M | 7.6% | +23.5% |
From the segment and revenue-disaggregation notes of Heartflow's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.